Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer

被引:29
作者
Alkatout, Ibrahim [1 ]
Wiedermann, Meike [2 ,3 ]
Bauer, Maret [1 ]
Wenners, Antonia [1 ]
Jonat, Walter [1 ]
Klapper, Wolfram [2 ,3 ]
机构
[1] Univ Hosp Schleswig Holstein, Dept Gynecol & Obstet, D-24105 Kiel, Germany
[2] Univ Hosp Schleswig Holstein, Dept Pathol, Hematopathol Sect, D-24105 Kiel, Germany
[3] Univ Hosp Schleswig Holstein, Lymph Node Registry, D-24105 Kiel, Germany
关键词
Breast cancer; Cancer stem cells; Epithelial-to-mesenchymal transition; Tumor heterogeneity; Tumor centre; Tumor margin; Snail; Slug; Twist; Zeb1; E-CADHERIN; BETA-CATENIN; PROGRESSION; EXPRESSION; CARCINOMA; MARKERS; SNAIL; SLUG; IDENTIFICATION; POLARITY;
D O I
10.1016/j.yexmp.2012.09.003
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Although tumor surgery aims for a complete resection respecting tumor-specific safety distance, in many cases the most peripheral part, the invasion front, remains in situ. Tumor cells at the tumor margin lose epithelial properties and acquire features of mesenchymal cells. The process of epithelial-to-mesenchymal transition (EMT) has been suggested to be of prime importance for tissue and vessel invasion. Recently, features of EMT were shown to be linked to cells with tumor-founding capability, so- called cancer stem cells (CSC). In this study we show that transcription factors associated with EMT markers Snail, Slug, Twist and Zeb1 are differentially expressed between normal breast epithelium, ductal carcinoma in situ and invasive breast cancer. Both invasive and in situ carcinoma expressed less Slug and Twist and more Zeb1 compared to normal epithelium. Using fluorescence multi-staining the number of potential CSC among invasive cancer cells varied dramatically depending on the staining combination used (18.5% for CD44(+)/CD24(-) and 2.4% for CD49f(+)/ CD24(+)). Interestingly, neither transcription factors associated with EMT nor potential CSC counts varied between tumor centre and invasion front. No association of these features with clinical outcome was detected. Our results suggest that reliable in situ markers for EMT are missing for invasive breast cancer. Alternatively, the process of EMT might be activated in tumor cells at the margin as well as the centre. Furthermore, our data show that the bin-markers of CSC detect very variable cell populations within breast cancer, challenging the assumption of a hierarchical organization of CSC in these tumors. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:168 / 173
页数:6
相关论文
共 50 条
  • [21] Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance
    Zhou, Jiaojiao
    Zhu, Xuan
    Wu, Shijie
    Guo, Jingxin
    Zhang, Kun
    Xu, Chunjing
    Chen, Huihui
    Jin, Yuxi
    Sun, Yuting
    Zheng, Shu
    Chen, Yiding
    CANCER BIOLOGY & MEDICINE, 2020, 17 (01) : 169 - +
  • [22] Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism
    Rahimian, A.
    Barati, G.
    Mehrandish, R.
    Mellati, A. A.
    MOLECULAR BIOLOGY, 2018, 52 (03) : 406 - 413
  • [23] Epithelial-mesenchymal transition and gastric cancer stem cell
    Xia, Pu
    Xu, Xiao-Yan
    TUMOR BIOLOGY, 2017, 39 (05)
  • [24] Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
    Dave, Bhuvanesh
    Mittal, Vivek
    Tan, Nicholas M.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2012, 14 (01):
  • [25] Transcriptional Factors for Epithelial-Mesenchymal Transition Are Associated with Mesenchymal Differentiation in Gliosarcoma
    Nagaishi, Masaya
    Paulus, Werner
    Brokinkel, Benjamin
    Vital, Anne
    Tanaka, Yuko
    Nakazato, Yoichi
    Giangaspero, Felice
    Ohgaki, Hiroko
    BRAIN PATHOLOGY, 2012, 22 (05) : 670 - 676
  • [26] Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients
    Gu, Siwen
    Chu, Chengyu
    Chen, Wanna
    Ren, Hong
    Cao, Yun
    Li, Xiaoyan
    He, Jing
    Wang, Yiwei
    Jin, Yiting
    Liu, Xiuping
    Zou, Qiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (06): : 2009 - +
  • [27] Twist expression associated with the epithelial-mesenchymal transition in gastric cancer
    Liu, Ai-ning
    Zhu, Zhi-Hua
    Chang, Shu-jian
    Hang, Xiao-sheng
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 367 (1-2) : 195 - 203
  • [28] Epithelial-mesenchymal transition and drug resistance in breast cancer
    Huang, Jing
    Li, Hongzhong
    Ren, Guosheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 840 - 848
  • [29] Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells
    Kim, Hyun A.
    Lee, Joomin
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [30] Epithelial-mesenchymal transition was identified as a potential marker for breast cancer aggressiveness using reverse transcription-quantitative polymerase chain reaction
    Andergassen, Ulrich
    Schlenk, Kristina
    Jeschke, Udo
    Sommer, Harald
    Koelbl, Alexandra
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 1733 - 1739